Pharmacists in Delano, California


30 Pharmacists found in Delano
female pharmacist

Ms. Maria Cecilia Sogueco Dee, RPH


Pharmacist
3000 W Cecil Ave, Delano, CA 93215
661-721-6355    

female pharmacist

Mee Young Lee


Pharmacist
1401 Garces Hwy, Delano, CA 93215
661-721-5302     661-721-5305

male pharmacist

Mr. Patrick Nelson Leroy, PHARM.D.


Pharmacist
1017 Ellington St, Delano, CA 93215
661-725-9489     661-725-3640



male pharmacist

Peter Vigil


Pharmacist
1017 Ellington St, Delano, CA 93215
661-725-9489    

female pharmacist

Dr. Raylene Therese Altmiller-rubio, PHARMD


Pharmacist
1017 Ellington St, Delano, CA 93215
661-725-9489     661-725-3640

male pharmacist

Richard Huynh, PHARM.D


Pharmacist
2737 W Cecil Ave, Delano, CA 93215
661-721-2345    

male pharmacist

Robert Jay Yang, PHARMD


Pharmacist
3000 W Cecil Ave, Delano, CA 93215
661-721-6300    

female pharmacist

Soyoung Lee


Pharmacist
1809 Cecil Ave, Delano, CA 93215
661-725-1312    

female pharmacist

Stephanie Jean Sun, PHARMD


Pharmacist
3000 W Cecil Ave, Delano, CA 93215
661-721-6300    

male pharmacist

Dr. Taegun Kim, PHARM.D.


Pharmacist
2737 W. Cecil Ave., Delano, CA 93215
661-721-2345    

female pharmacist

Thao Phan


Pharmacist
1809 Cecil Ave, Delano, CA 93215
661-725-1312    

male pharmacist

Tze Leung Liu, PHARM.D


Pharmacist
1435 High St, Delano, CA 93215
661-721-2294    

female pharmacist

Yasamin Jorat


Pharmacist
912 Fremont St, Delano, CA 93215
866-707-6664    

female pharmacist

Yeseul Yoo, PHARMD


Pharmacist
2737 W Cecil Ave, Delano, CA 93215
661-721-2345    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.